Literature DB >> 29556692

Impact of reduced forced expiratory volume on cardiac prognosis in patients with chronic heart failure.

Yuki Honda1, Tetsu Watanabe2, Yoichiro Otaki3, Harutoshi Tamura3, Satoshi Nishiyama3, Hiroki Takahashi3, Takanori Arimoto3, Tetsuro Shishido3, Takuya Miyamoto3, Yoko Shibata4, Isao Kubota4.   

Abstract

In patients with chronic heart failure (CHF), comorbidity of airflow limitation is associated with poor outcomes. The forced expiratory volume in 1 s (FEV1) is used to evaluate the severity of airflow limitation. However, the impact of FEV1 severity on prognosis has only been partially elucidated in patients with CHF. In total, 248 consecutive patients with CHF who successfully fulfilled spirometric measurement criteria were enrolled and prospectively followed. Percent predicted FEV1 (FEV1%predicted) was associated with the New York Heart Association Functional Classification. FEV1%predicted was significantly associated with diastolic dysfunction, evaluated using echocardiography; elevated inflammation markers; and increased pulmonary arterial pressure. There were 60 cardiac events, including 9 cardiac-related deaths and 51 re-hospitalizations due to the exacerbation of CHF during a follow-up period. Kaplan-Meier analysis revealed that the lowest FEV1%predicted group had the highest event rate, irrespective of the presence of smoking history. Multivariate Cox proportional hazard analysis showed that FEV1%predicted was an independent predictor of cardiac events after adjusting for confounders. The net reclassification improvement and integrated discrimination improvement were improved by the addition of FEV1%predicted to other cardiac risk factors. Decreased FEV1%predicted was independently associated with the poor cardiac outcomes in patients with CHF.

Entities:  

Keywords:  Airflow limitation; Chronic heart failure; Chronic obstructive pulmonary disease; FEV1%predicted

Mesh:

Year:  2018        PMID: 29556692     DOI: 10.1007/s00380-018-1153-1

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  26 in total

1.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.

Authors:  B R Celli; W MacNee
Journal:  Eur Respir J       Date:  2004-06       Impact factor: 16.671

2.  Diastolic Dysfunction Is a Contributing Factor to Exercise Intolerance in COPD.

Authors:  Réka Faludi; Máté Hajdu; Vivien Vértes; Ágnes Nógrádi; Noémi Varga; Miklós Balázs Illés; Veronika Sárosi; György Alexy; András Komócsi
Journal:  COPD       Date:  2015-12-18       Impact factor: 2.409

3.  [Guideline of respiratory function tests--spirometry, flow-volume curve, diffusion capacity of the lung].

Authors: 
Journal:  Nihon Kokyuki Gakkai Zasshi       Date:  2004-11

4.  Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-24       Impact factor: 79.321

Review 5.  Exercise intolerance in heart failure: update on exercise parameters for diagnosis, prognosis and therapeutic interventions.

Authors:  Sofie Pardaens; Patrick Calders; Eric Derom; Johan De Sutter
Journal:  Acta Cardiol       Date:  2013-10       Impact factor: 1.718

6.  Percent emphysema, airflow obstruction, and impaired left ventricular filling.

Authors:  R Graham Barr; David A Bluemke; Firas S Ahmed; J Jeffery Carr; Paul L Enright; Eric A Hoffman; Rui Jiang; Steven M Kawut; Richard A Kronmal; João A C Lima; Eyal Shahar; Lewis J Smith; Karol E Watson
Journal:  N Engl J Med       Date:  2010-01-21       Impact factor: 91.245

Review 7.  Systemic manifestations and comorbidities of COPD.

Authors:  P J Barnes; B R Celli
Journal:  Eur Respir J       Date:  2009-05       Impact factor: 16.671

8.  The impact of heart failure on the classification of COPD severity.

Authors:  Gülmisal Güder; Frans H Rutten; Susanne Brenner; Christiane E Angermann; Dominik Berliner; Georg Ertl; Berthold Jany; Jan-Willem J Lammers; Arno W Hoes; Stefan Störk
Journal:  J Card Fail       Date:  2012-07-13       Impact factor: 5.712

9.  Airway inflammation in Japanese COPD patients compared with smoking and nonsmoking controls.

Authors:  Nobuhisa Ishikawa; Noboru Hattori; Nobuoki Kohno; Akihiro Kobayashi; Tomoyuki Hayamizu; Malcolm Johnson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-01-23

10.  Pulmonary venous hypertension and mechanical strain stimulate monocyte chemoattractant protein-1 release and structural remodelling of the lung in human and rodent chronic heart failure models.

Authors:  John E S Park; Alexander R Lyon; Dongmin Shao; Lauren R Hector; Hua Xu; Peter O'Gara; Liao Pinhu; Rachel C Chambers; S John Wort; Mark J D Griffiths
Journal:  Thorax       Date:  2014-09-15       Impact factor: 9.139

View more
  1 in total

1.  The clinical characteristics and outcomes of heart failure patient with chronic obstructive pulmonary disease from the Japanese community-based registry.

Authors:  Kensuke Takabayashi; Yuka Terasaki; Miyuki Okuda; Osamu Nakajima; Hitoshi Koito; Tetsuhisa Kitamura; Shouji Kitaguchi; Ryuji Nohara
Journal:  Heart Vessels       Date:  2020-08-07       Impact factor: 2.037

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.